Advertisement

Quality of Life Research

, Volume 25, Issue 9, pp 2295–2306 | Cite as

Change in quality of life and one-year mortality risk in maintenance dialysis patients

  • Scott Liebman
  • Nien-Chen Li
  • Eduardo Lacson
Article

Abstract

Background

Quality of life (QOL) is an important metric of high-quality dialysis care. QOL is commonly measured by the Short Form 36 Questionnaire (SF-36), which provides two summary scores: a mental component score (MCS) and a physical component score (PCS). Poor QOL is associated with mortality in dialysis patients. Small studies show that changes in QOL also predicts mortality. We investigated whether changes in QOL over time are associated with mortality in a large cohort of maintenance hemodialysis patients.

Methods

This retrospective study was conducted in 1017 outpatient dialysis facilities. Over 10,000 hemodialysis patients completed two SF-36 surveys. We compared 1-year morality rates in those whose MCS or PCS increased or decreased ±5 vs. those whose did not.

Results

For those who completed two surveys, mean score for PCS was unchanged, whereas MCS increased slightly (48.6 vs. 48.9, p = 0.05). Individual patients, however, showed marked variation. On the second survey, more than half of patients demonstrated a ± 5 point change in the PCS and/or MCS. After multivariate adjustment, a ≥ 5 decrease in MCS was associated with an increase in mortality (HR = 1.33, 95 % CI 1.18, 1.50).

Conclusions

Clinicians should be aware that many patients experience a significant change in both the MCS and PCS on dialysis. A MCS decrease of ≥5 was associated with increased mortality. More study is needed to determine whether this is a causal relationship. Physicians should evaluate root causes and seek to mitigate declines in QOL whenever possible.

Keywords

Quality of life Dialysis Survival Outcomes research Psychosocial issues 

Notes

Acknowledgments

Part of this work was presented in abstract form at the National Kidney Foundation’s Spring Clinical Meetings, 2012, Washington DC. We acknowledge the (non-financial) support of Frenova Renal Research, a Fresenius Medical Care North America company.

Funding

There was no support/funding for this study.

Compliance with ethical standards

Conflict of interest

Nien-Chen Li is an employee of FMCNA. Dr. Lacson was a full-time employee of FMCNA when the analyses were completed, but he has since moved to the Tufts University School of Medicine. Dr. Liebman has no conflicts of interest.

Informed consent

The survey results and clinical data were obtained as part of routine clinical care, for which all incoming hemodialysis patients provide consent.

Human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Supplementary material

11136_2016_1257_MOESM1_ESM.docx (17 kb)
Supplementary material 1 (DOCX 16 kb)

References

  1. 1.
    Abdel-Kader, K., Unruh, M. L., & Weisbord, S. D. (2009). Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clinical Journal of the American Society of Nephrology, 4(6), 1057–1064.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Rayner, H. C., Zepel, L., Fuller, D. S., Morgenstern, H., Karaboyas, A., Culleton, B. F., et al. (2014). Recovery time, quality of life, and mortality in hemodialysis patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases, 64(1), 86–94.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    K/DOQI. (2002). Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases, 39(2 Suppl 1), S1–S266.Google Scholar
  4. 4.
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2013). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter, 3(1), 19–62.CrossRefGoogle Scholar
  5. 5.
    Ware, J., Snow, K., Kosinski, M., & Gandeck, B. (1993). SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New England Medical Center.Google Scholar
  6. 6.
    DeOreo, P. B. (1997). Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. American Journal of Kidney Diseases, 30(2), 204–212.CrossRefPubMedGoogle Scholar
  7. 7.
    Lacson, E., Xu, J., Lin, S.-F., Dean, S. G., Lazarus, J. M., & Hakim, R. M. (2010). A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients. Clinical Journal of the American Society of Nephrology, 5(2), 252–260.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Lacson, E, Jr, Wang, W., Lazarus, J. M., & Hakim, R. M. (2009). Hemodialysis facility-based quality-of-care indicators and facility-specific patient outcomes. American Journal of Kidney Diseases, 54(3), 490–497.CrossRefPubMedGoogle Scholar
  9. 9.
    Lowrie, E. G., Curtin, R. B., LePain, N., & Schatell, D. (2003). Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. American Journal of Kidney Diseases, 41(6), 1286–1292.CrossRefPubMedGoogle Scholar
  10. 10.
    Mapes, D. L., Bragg-Gresham, J. L., Bommer, J., Fukuhara, S., McKevitt, P., Wikström, B., & Lopes, A. A. (2004). Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases, 44(Supplement 2(0)), 54–60.CrossRefPubMedGoogle Scholar
  11. 11.
    Mittal, S. K., Ahern, L., Flaster, E., Maesaka, J. K., & Fishbane, S. (2001). Self-assessed physical and mental function of haemodialysis patients. Nephrology, Dialysis, Transplantation, 16(7), 1387–1394.CrossRefPubMedGoogle Scholar
  12. 12.
    Wu, A. W., Fink, N. E., Marsh-Manzi, J. V. R., Meyer, K. B., Finkelstein, F. O., Chapman, M. M., & Powe, N. R. (2004). Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. Journal of the American Society of Nephrology, 15(3), 743–753.CrossRefPubMedGoogle Scholar
  13. 13.
    Kušleikaitė, N., Bumblytė, I. A., Kuzminskis, V., & Vaičiūnienė, R. (2010). The association between health-related quality of life and mortality among hemodialysis patients. Medicina, 46(8), 531–537. (Kaunas).PubMedGoogle Scholar
  14. 14.
    Unruh, M. L., Newman, A. B., Larive, B., Amanda Dew, M., Miskulin, D. C., Greene, T., et al. (2008). The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis. Journal of the American Geriatrics Society, 56(9), 1608–1617.CrossRefPubMedGoogle Scholar
  15. 15.
    Bakewell, A. B., Higgins, R. M., & Edmunds, M. E. (2002). Quality of life in peritoneal dialysis patients: decline over time and association with clinical outcomes. Kidney International, 61(1), 239–248.CrossRefPubMedGoogle Scholar
  16. 16.
    Merkus, M. P., Jager, K. J., Dekker, F. W., de Haan, R. J., Boeschoten, E. W., & Krediet, R. T. (1999). Quality of life over time in dialysis: The Netherlands Cooperative Study on the Adequacy of Dialysis. Kidney International, 56(2), 720–728.CrossRefPubMedGoogle Scholar
  17. 17.
    Fan, V. S., Au, D. H., McDonell, M. B., & Fihn, S. D. (2004). Intraindividual change in SF-36 in ambulatory clinic primary care patients predicted mortality and hospitalizations. Journal of Clinical Epidemiology, 57(3), 277–283.CrossRefPubMedGoogle Scholar
  18. 18.
    Michaud, K., Vera-Llonch, M., & Oster, G. (2012). Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis. The Journal of Rheumatology, 39(1), 54–59.CrossRefPubMedGoogle Scholar
  19. 19.
    Patterson, R., Saquib, N., Natarajan, L., Rock, C., Parker, B., Thomson, C., & Pierce, J. (2011). Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer. Breast Cancer Research and Treatment, 127(2), 541–547.CrossRefPubMedGoogle Scholar
  20. 20.
    Knight, E. L., Ofsthun, N., Teng, M., Lazarus, J. M., & Curhan, G. C. (2003). The association between mental health, physical function, and hemodialysis mortality. Kidney International, 63(5), 1843–1851.CrossRefPubMedGoogle Scholar
  21. 21.
    Gotch, F. A. (1998). The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrology, Dialysis, Transplantation, 13(suppl 6), 10–14.CrossRefPubMedGoogle Scholar
  22. 22.
    Angst, F., Aeschlimann, A., & Stucki, G. (2001). Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Care and Research, 45(4), 384–391.CrossRefPubMedGoogle Scholar
  23. 23.
    Coteur, G., Feagan, B., Keininger, D. L., & Kosinski, M. (2009). Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn’s disease. Alimentary Pharmacology and Therapeutics, 29(9), 1032–1041.CrossRefPubMedGoogle Scholar
  24. 24.
    Frendl, D. M., & Ware, J. E. J. (2014). Patient-reported functional health and well-being outcomes with drug therapy: a systematic review of randomized trials using the SF-36 health survey. Medical Care, 52(5), 439–445.CrossRefPubMedGoogle Scholar
  25. 25.
    Ingram, M., Choi, Y. H., Chiu, C.-Y., Haggard, R., Dougall, A. L., Buschang, P., & Gatchel, R. J. (2011). Use of the minimal clinically important difference (mcid) for evaluating treatment outcomes with TMJMD patients: a preliminary study. Journal of Applied Biobehavioral Research, 16(3–4), 148–166.CrossRefPubMedGoogle Scholar
  26. 26.
    Cohen, J. (1969). Statistical power analysis for the behavioral sciences. New York: Academic Press.Google Scholar
  27. 27.
    Moura, A., Madureira, J., Alija, P., Fernandes, J. C., Oliveira, J. G., Lopez, M., et al. (2014). Type of vascular access and location in online hemodiafiltration and its association with patient’s perception of health-related quality of life. The Journal of Vascular Access, 15(3), 175–182.CrossRefPubMedGoogle Scholar
  28. 28.
    Wasse, H., Kutner, N., Zhang, R., & Huang, Y. (2007). Association of initial hemodialysis vascular access with patient-reported health status and quality of life. Clinical Journal of the American Society of Nephrology, 2(4), 708–714.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Pisoni, R. L., Arrington, C. J., Albert, J. M., Ethier, J., Kimata, N., Krishnan, M., et al. (2009). Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. American Journal of Kidney Diseases, 53(3), 475–491.CrossRefPubMedGoogle Scholar
  30. 30.
    Tentori, F., Elder, S. J., Thumma, J., Pisoni, R. L., Bommer, J., Fissell, R. B., et al. (2010). Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes. Nephrology, Dialysis, Transplantation, 25(9), 3050–3062.CrossRefPubMedGoogle Scholar
  31. 31.
    Brekke, F. B., Waldum, B., Amro, A., Østhus, T. B. H., Dammen, T., Gudmundsdottir, H., & Os, I. (2014). Self-perceived quality of sleep and mortality in Norwegian dialysis patients. Hemodialysis International, 18(1), 87–94.CrossRefPubMedGoogle Scholar
  32. 32.
    Iliescu, E. A., Coo, H., McMurray, M. H., Meers, C. L., Quinn, M. M., Singer, M. A., & Hopman, W. M. (2003). Quality of sleep and health-related quality of life in haemodialysis patients. Nephrology, Dialysis, Transplantation, 18(1), 126–132.CrossRefPubMedGoogle Scholar
  33. 33.
    Farrokhi, F., Abedi, N., Beyene, J., Kurdyak, P., & Jassal, S. V. (2014). Association between depression and mortality in patients receiving long-term dialysis: A systematic review and meta-analysis. American Journal of Kidney Diseases, 63(4), 623–635.CrossRefPubMedGoogle Scholar
  34. 34.
    Oliveira, C. M. C., Costa, S. P., Costa, L. C., Pinheiro, S. M., Lacerda, G. A., & Kubrusly, M. (2012). Depression in dialysis patients and its association with nutritional markers and quality of life. Journal of Nephrology, 25(6), 945–961.CrossRefGoogle Scholar
  35. 35.
    Miskulin, D. C., Meyer, K. B., Martin, A. A., Fink, N. E., Coresh, J., Powe, N. R., et al. (2003). Comorbidity and its change predict survival in incident dialysis patients. American Journal of Kidney Diseases, 41(1), 149–161.CrossRefPubMedGoogle Scholar
  36. 36.
    Lopes, A., Bragg-Gresham, J., Goodkin, D., Fukuhara, S., Mapes, D., Young, E., et al. (2007). Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Quality of Life Research, 16(4), 545–557.CrossRefPubMedGoogle Scholar
  37. 37.
    Moreno, F., Gomez, J. M. L., Sanz-Guajardo, D., Jofre, R., Valderrábano, F. (1996). Quality of life in dialysis patients. A Spanish multicentre study. Nephrology Dialysis Transplantation, 11(supp2), 125–129.CrossRefGoogle Scholar
  38. 38.
    Mucsi, I., Kovacs, A., Molnar, M., & Novak, M. (2008). Co-morbidity and quality of life in chronic kidney disease patients. Journal of Nephrology, 21(Suppl 13), S84–S91.PubMedGoogle Scholar
  39. 39.
    Unruh, M. L., Evans, I. V., Fink, N. E., Powe, N. R., & Meyer, K. B. (2005). Skipped Treatments, Markers of Nutritional Nonadherence, and Survival Among Incident Hemodialysis Patients. American journal of kidney diseases: the official journal of the National Kidney Foundation, 46(6), 1107–1116.CrossRefGoogle Scholar
  40. 40.
    Overbeck, I., Bartels, M., Decker, O., Harms, J., Hauss, J., & Fangmann, J. (2005). Changes in quality of life after renal transplantation. Transplantation Proceedings, 37(3), 1618–1621.CrossRefPubMedGoogle Scholar
  41. 41.
    Jaar, B. G., Chang, A., & Plantinga, L. (2013). Can we improve quality of life of patients on dialysis? Clinical Journal of the American Society of Nephrology, 8(1), 1–4.CrossRefPubMedGoogle Scholar
  42. 42.
    Mazairac, A. H. A., de Wit, G. A., Grooteman, M. P. C., Penne, E. L., van der Weerd, N. C., den Hoedt, C. H., et al. (2013). Effect of hemodiafiltration on quality of life over time. Clinical Journal of the American Society of Nephrology, 8(1), 82–89.CrossRefPubMedGoogle Scholar
  43. 43.
    Finkelstein, F. O., Schiller, B., Daoui, R., Gehr, T. W., Kraus, M. A., Lea, J., et al. (2012). At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney International, 82(5), 561–569.CrossRefPubMedGoogle Scholar
  44. 44.
    Harris, S., Lamping, D., Brown, E., & Constantinovici, N. (2002). Clinical outcomes and quality of life in elderly patients on peritoneal dialysis versus hemodialysis. Peritoneal Dialysis International, 22(4), 463–470.PubMedGoogle Scholar
  45. 45.
    Aramwit, P., Keongamaroon, O., Siritientong, T., Bang, N., & Supasyndh, O. (2012). Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study. BMC Nephrology, 13(1), 119.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Duarte, P. S., Miyazaki, M. C., Blay, S. L., & Sesso, R. (2009). Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney International, 76(4), 414–421.CrossRefPubMedGoogle Scholar
  47. 47.
    Finkelstein, F. O., Shirani, S., Wuerth, D., & Finkelstein, S. H. (2007). Therapy insight: sexual dysfunction in patients with chronic kidney disease. Nature Clinical Practice Nephrology, 3(4), 200–207.CrossRefPubMedGoogle Scholar
  48. 48.
    Ouzouni, S., Kouidi, E., Sioulis, A., Grekas, D., & Deligiannis, A. (2009). Effects of intradialytic exercise training on health-related quality of life indices in haemodialysis patients. Clinical Rehabilitation, 23(1), 53–63.CrossRefPubMedGoogle Scholar
  49. 49.
    Foley, R. N., Curtis, B. M., & Parfrey, P. S. (2009). Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clinical Journal of the American Society of Nephrology, 4(4), 726–733.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., et al. (1998). The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. New England Journal of Medicine, 339(9), 584–590.CrossRefPubMedGoogle Scholar
  51. 51.
    USRDS. (2015). Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.University of Rochester Medical CenterRochesterUSA
  2. 2.Fresenius Medical Care North AmericaWalthamUSA
  3. 3.Tufts University School of MedicineBostonUSA

Personalised recommendations